Global Interventional Cardiology Devices Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Interventional Cardiology Devices Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Interventional cardiology deals with the treatment of the heart related diseases such as coronary artery disease, congenital heart defect and aneurysm through catheter-based devices. The process involves the insertion of catheter into large peripheral artery or vein to perform surgical process.

Market Overview:

The latest research study on the global Interventional Cardiology Devices market finds that the global Interventional Cardiology Devices market reached a value of USD 15775.61 million in 2022. It’s expected that the market will achieve USD 20775.85 million by 2028, exhibiting a CAGR of 4.7% during the forecast period.

Market Driving Force

Changing the lifestyle characterized by smoking, high alcohol consumption and lack of physical exercise increases the prevalence of coronary artery disease, thereby driving the development of the interventional heart disease equipment industry.
Continued technological advances in the interventional cardiology equipment market are driving adoption, and the growing demand for safety and advanced technology is driving the growth of the global market for interventional cardiology equipment.
The increasing number of elderly populations around the world and the need to improve medical equipment have driven the growth of the market for interventional cardiology equipment.

Region Overview:

From 2023-2028, North America is estimated to witness robust growth prospects.

Company Overview:

The top three companies are Boston Scientific, Medtronic, Terumo. with the revenue market share of 19.97%, 16.73% and 14.51% in 2018.

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional Cardiology Devices.

Medtronic plc is the world's largest medical device company that generates the majority of its sales and profits from the U.S. healthcare system.

Segmentation Overview:

Among different product types, Angioplasty segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Hospital segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Interventional Cardiology Devices market covered in Chapter 3:

C. R. BARD
CORDIS
B. BRAUN
BIOSENSORS
BIOTRONIK
Terumo
ABBOTT
Medtronic
BOSTON SCIENTIFIC

In Chapter 4 and Chapter 14.2, on the basis of types, the Interventional Cardiology Devices market from 2018 to 2029 is primarily split into:

Angioplasty
Catheters
Plaque Modification
Hemodynamic Flow Alteration

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Interventional Cardiology Devices market from 2018 to 2029 covers:

Hospital
Clinic

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)